The Roots Analysis team is putting in its best effort to offer our clients / readers a reliable source of information, regarding how the pharmaceutical and biotech sectors are coping in the midst of the COVID-19 pandemic. Our intention is to generate realistic insights, based on a variety of factors, which are anticipated to influence both prevalent and future market dynamics. Reach out to us for any help.

Needlestick Safety Injection Devices, 2014 - 2024

  • Lowest Price Guaranteed From USD 1,899

  • Published
    October 2014

  • Pages
    226

  • View Count
    7334

Example Insights

  1. During our research, we identified 72 safety injection devices manufactured by 39 companies. Out of these, 46 were safety syringes, followed by safety needles (17) and other add-on safety tools (9).
  2. Becton Dickinson, Covidien and Terumo Medical Corporation are amongst the pioneers in the safety injection devices industry. The market however is fragmented and 58% of the safety injection devices are manufactured by smaller companies.
  3. The use of safety syringes has been mandated in the US; Europe and other international markets are moving towards the use and adoption of these devices. In addition to the established companies in the US and the Europe, the market has witnessed the emergence of some regional players including Beipu, UNIQSAFE Biomeditech Company and Formosa Medical Devices.
  4. Technological advancements are likely to be one of the primary drivers of the market. Examples include the emergence of needleless systems and prefilled syringes with safety features.
  5. The global market for safety syringes is likely to grow at a CAGR of 9.0% during 2014 – 2024. Non-retractable syringes currently capture a larger share of the total market. However, it is anticipated that wider customer adoption and declining prices will likely result in retractable syringes gaining a larger share of the pie in the coming decade.

 

Overview

With increasing awareness about occupational safety and growing concern on the prevention of needlestick injury, safety injection devices have gained increased attention from the manufacturers and healthcare professionals worldwide. The accelerated emergence of regulatory controls over the past few years have further ensured that manufacturers come up with modifications in the product design and integrated safety controls to meet the requirements.

Safety injection devices, which include safety syringes and safety needles, are designed to enhance safety of the drug administration process and eliminate needlestick injuries - a major cause of blood-borne infections. The current growth in the market for a variety of safety injection devices is primarily underpinned by the evolving needs of the patients and the requirement for better and safer syringe systems.

These devices have several advantages over traditional drug delivery systems. Most importantly, the addition of safety feature provides optimal protection to the healthcare practitioners and patients, reducing the risk of accidental needlestick injuries. Specifically, in case of a retractable syringe, the needle is locked into the barrel of the syringe and the entire assembly can be safely disposed of. The cost of disposal of a safety syringe is relatively much lower compared to a conventional syringe. Despite a marginally relatively higher purchase price, these devices are known to offer long term economic advantage if the consequences of a needlestick injury and associated treatment expenses are taken into consideration.

In addition to the existing established device manufacturers, the market has seen the presence of some relatively new players. These start-ups have recently introduced some important safety devices with innovative features. The need for improvement in safety mechanisms and functionality of the devices will continue to present positive growth prospects for the market in the foreseeable future.

 

Scope of the Report

The ‘Needlestick Safety Injection Devices Market, 2014-2024’ report provides an extensive study of the growing market of safety injection devices. This includes safety syringes, safety needles and other add-on safety tools. Due to the recent surge of regulations and the need for injection safety at healthcare settings, safety injection devices have emerged as one of the key focus areas for device manufacturers. The market is characterized by the presence of around 70 safety injection devices providing optimal protection from needlestick injuries to the patients as well as caregivers. When compared to the conventional drug delivery systems, these devices offer several other advantages including convenient disposal and long-term economic advantage. The focus of this report is primarily to understand the governing trends and the likely future evolution of these devices over the next decade.

The report covers various aspects such as regulatory guidelines, market developments, recent partnerships and our opinion on the likely drivers which will influence the industry’s evolution. In addition, we have provided a holistic view of the market landscape including detailed profiles of leading devices, key features and their comparative position vis-à-vis other devices. The future growth in the market will primarily be driven by the rapidly expanding injectable drugs market and regulatory legislations encouraging the use of safety injection devices. Innovation in design and advanced safety mechanisms will continue to present development prospects in the years ahead.

Despite some of these key benefits and a promising future, the study also highlights considerable challenges associated with the use and implementation of these devices. The modification in design and incorporation of safety features present operational challenges to the administrators. Furthermore, cost is yet another factor that can significantly restrain the market in the short term. However, as the sales volume gains momentum, prices are expected to come down which will further drive the uptake of such devices.

The base year for the report is 2013. The study provides short-midterm and long term market forecasts for the period 2014 - 2019 and 2019 - 2024, respectively. The research, analysis and insights presented in this report is backed by a deep understanding of key insights gathered from both secondary and primary research.

Contents

Chapter 2  provides an executive summary of the insights captured in our research. The summary offers a high level view on the likely evolution of safety injection devices.

Chapter 3  provides a general introduction on the safety injection devices. We have also covered, in detail, the concept behind needlestick injuries, regulatory landscape, categorization of safety devices and associated challenges with the use of such devices.

Chapter 4  identifies the various safety devices available in the market; these include safety syringes, safety needles and add-on safety tools. The chapter also provides details on some alternative needle based safety devices including safety blood collection/infusion sets, auto-injectors, blunt fill needles and needleless injection and connector systems.

Chapter 5  includes analysis of various safety syringes that are available in the market, with detailed description on retractable and non-retractable syringes. An in-depth review, including distribution by type of safety feature, mode of activation, and analysis by price, has been covered in this chapter. The chapter also includes a comprehensive section on product profiles wherein all the safety syringes identified have been explained, with information on the product development history, usage/mechanism and key advantages.

Chapter 6  focuses specifically on safety needles that are currently available in the market. It provides a comprehensive review of the key parameters related to these devices including the mode of activation and price. In addition, it includes profiles of all the safety needles we were able to identify in the research.

Chapter 7  analyzes the market developments with respect to safety injection devices. It discusses the drugs and therapeutic products that are marketed along with the safety devices. It also contains information about the partnerships in this field that have taken place in the past few years.

Chapter 8  presents a detailed ten year forecast for the safety syringes market. Due to the uncertainty surrounding some of the key assumptions, we have presented three different growth tracks outlined as conservative, base and optimistic scenarios.

Chapter 9  includes profiles of key companies active in the safety injection devices market. Each company profile includes information such as financial performance, product portfolio, recent developments and future growth outlook.

Chapter 10  provides information on the regional/other manufacturers which have been actively involved in the market. The chapter also contains a section on the comparison of product portfolio for these companies.

Chapter 11  provides the SWOT analysis of the safety injection devices market giving strategic insights to the major factors that are likely to drive future growth while also highlighting the weakness and threats that can negatively impact the industry’s evolution.

Chapter 12  is a collection of transcripts of interviews conducted during the course of this study.

Chapter 13  summarizes the overall report. In this chapter, we provide a recap of the key takeaways and our independent opinion based on the research and analysis described in previous chapters.

Chapter 14  is an appendix which provides tabulated data and numbers for all the figures provided in the report.

Chapter 15  is an appendix which provides a list of companies and organizations mentioned in the report.

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
 
2. EXECUTIVE SUMMARY
 
3. INTRODUCTION
3.1. Context and Background
3.2. Needlestick Injuries
3.2.1. Incidence and Cost Burden
3.3. Needle Safety Devices: Definition
3.4. OSHA: Categorization of Needle Safety Devices
3.5. Needle Safety Devices: Desirable Characteristics
3.6. Needle Safety Devices: Challenges
3.7. Regulatory Landscape
3.7.1. Federal Regulations
3.7.1.1. Needlestick Safety and Prevention Act
3.7.1.2. Regional Compliance
3.7.2. State Regulations
3.7.3. International Regulations
 
4. MARKET OVERVIEW
4.1. Chapter Overview
4.2. Safety Injection Devices
4.2.1. Safety Injection Devices: Distribution by Type
4.2.2. Safety Injection Devices: Manufacturer’s Landscape
4.3. Cost Comparison
4.4. Other Devices
4.4.1. Safety Blood Collection / Infusion Sets
4.4.2. Autoinjectors
4.4.2.1. Pen Injectors vs. Autoinjectors
4.4.2.2. Safety Options in Self Injectors
4.4.3. Blunt Fill Needles
4.4.4. Needle Free Injection Technology
 
5. SAFETY SYRINGES
5.1. Chapter Overview
5.2. Components of a Safety Syringe
5.3. Types of Safety Syringes
5.4. Retractable Syringes
5.4.1. List of Retractable Syringes
5.5. Non Retractable/ Needle Shield Syringes
5.5.1. List of Non-Retractable Safety Syringes
5.6. Analysis by Price
5.7. Mapping the Competitive Landscape
 
5.8. Product Profiles
5.8.1. Section Overview
5.8.2. RevVac Safety Syringe
5.8.2.1. Introduction
5.8.2.2. Product Description
5.8.2.3. Development History
5.8.2.4. Usage/Mechanism
5.8.2.5. Advantages
 
5.8.3. Unifill Syringe
5.8.3.1. Introduction
5.8.3.2. Product Description
5.8.3.3. Development History
5.8.3.4. Usage/Mechanism
5.8.3.5. Advantages
 
5.8.4. The FreeVac Safety Syringe
5.8.4.1. Introduction
5.8.4.2. Product Description
5.8.4.3. Development History
5.8.4.4. Usage/Mechanism
5.8.4.5. Advantages
 
5.8.5. VanishPoint Syringe
5.8.5.1. Introduction
5.8.5.2. Product Description
5.8.5.3. Development History
5.8.5.4. Usage/Mechanism
5.8.5.5. Advantages
 
5.8.6. Mysafety Syringe
5.8.6.1. Introduction
5.8.6.2. Product Description
5.8.6.3. Development History
5.8.6.4. Mechanism/Usage
5.8.6.5. Advantages
 
5.8.7. MedPro Passive Safety Syringe
5.8.7.1. Introduction
5.8.7.2. Product Description
5.8.7.3. Development History
5.8.7.4. Usage/Mechanism
5.8.7.5. Advantages
5.8.8. SafePro Plus Safety Syringe
5.8.8.1. Introduction
5.8.8.2. Product Description
5.8.8.3. Development History
5.8.8.4. Usage/Mechanism
5.8.8.5. Advantages
 
5.8.9. Syringex Safety Syringe
5.8.9.1. Introduction
5.8.9.2. Product Description
5.8.9.3. Development History
5.8.9.4. Usage/Mechanism
5.8.9.5. Advantages
 
5.8.10. UNIQSAFE Safety Syringe
5.8.10.1. Introduction
5.8.10.2. Product Description
5.8.10.3. Development History
5.8.10.4. Usage/Mechanism
5.8.10.5. Advantages
 
5.8.11. BakSnap Retractable Safety Syringe
5.8.11.1. Introduction
5.8.11.2. Product Description
5.8.11.3. Usage/Mechanism
5.8.11.4. Advantages
 
5.8.12. BD Safety-Lok Syringe
5.8.12.1. Introduction
5.8.12.2. Product Description
5.8.12.3. Development History
5.8.12.4. Usage/Mechanism
5.8.12.5. Advantages
 
5.9. Other Safety Syringes
5.9.1. SureSafe Retractable Syringe
5.9.2. Medicina Safety Syringes
5.9.3. Medigard Safety Syringes
5.9.4. Elite Safety Syringe
5.9.5. The Protectus Safety Syringe
5.9.6. Q Stat Safety Syringe
5.9.7. SecureTouch Syringe
5.9.8. Ultra Safety Plus XL Safety Syringe
5.9.9. Needle-Pro Edge Safety Device
5.9.10. SOL-CARE Luer Lock Safety Syringe
5.9.11. SafeSnap Safety Syringe
5.9.12. BD Integra Syringe with Retracting PrecisionGlide Needle
5.9.13. Star ID device
5.9.14. SurGuard3 Hypodermic Syringe with Safety Needle
5.9.15. Wenzhou Safety Syringe
5.9.16. Magellan Hypodermic Safety Needle & Syringe Combinations
5.9.17. Monoject Safety Syringes
5.9.18. ClickZip Needle Retractable Safety Syringe
5.9.19. RauSafe
5.9.20. Fulject Safety Syringe
5.9.21. Epiphany Safe Shot Safety Syringe
5.9.22. BD Safety Glide Syringe for Insulin, TB and Allergy
 
6. SAFETY NEEDLES
6.1. Chapter Overview
6.2. Types of Safety Needles
6.3. Distribution by Mode of Activation
6.4. List of Safety Needles
6.5. Analysis by Price
 
6.6. Product Profiles
6.6.1. Section Overview
6.6.2. K-Pack Surshield Needle
6.6.2.1. Introduction
6.6.2.2. Product Description
6.6.2.3. Mechanism/Usage
6.6.2.4. Advantages
6.6.2.5. Current Status
 
6.6.3. NovaGuard
6.6.3.1. Introduction
6.6.3.2. Product Description
6.6.3.3. Mechanism/Usage
6.6.3.4. Advantages
6.6.3.5. Current Status
 
6.6.4. SurGuard3 Hypodermic Syringe with Safety Needle
6.6.4.1. Introduction
6.6.4.2. Product Description
6.6.4.3. Mechanism/Usage
6.6.4.4. Advantages
 
6.6.5. BD AutoShield Duo Pen Needle
6.6.5.1. Introduction
6.6.5.2. Product Description
6.6.5.3. Mechanism/Usage
6.6.5.4. Advantages
6.6.5.5. Current Status
 
6.6.6. BD SafetyGlide Shielding Hypodermic Needle
6.6.6.1. Introduction
6.6.6.2. Product Description
6.6.6.3. Mechanism/Usage
6.6.6.4. Advantages
6.6.6.5. Current Status
 
6.7. Other Safety Needles
6.7.1. BD Eclipse Needle
6.7.2. Wenzhou Safety Insulin Pen Needle
6.7.3. The Click In Safety Shield System
6.7.4. Magellan Hypodermic Safety Needles
6.7.5. Novo Nordisk NovoFine Autocover
6.7.6. Safety Tip needles
6.7.7. Needle-Trap device
6.7.8. Med-Lok Safety Needle
6.7.9. Autosafe-Reflex Safety Needle
 
7. MARKET DEVELOPMENTS
7.1. Marketed Drugs in/with Safety Devices
7.2. Deals and Partnerships
 
8. MARKET SIZE AND FORECAST
8.1. Chapter Overview
8.2. Forecast Methodology
8.3. Overall Safety Syringes Market, 2014-2024 (Value and Volume)
8.4. Retractable Safety Syringes Market, 2014- 2024 (Value and Volume)
8.5. Non-retractable Safety Syringes Market, 2014- 2024 (Value and Volume)
 
9. COMPANY PROFILES
9.1. Chapter Overview
9.2. Unilife Corporation
9.2.1. Overview and Background
9.2.2. Financial Performance
9.2.3. Product Portfolio
9.2.3.1. Unifill Platform of Prefilled Syringes
9.2.3.2. EZMix Platform of Dual-Chamber Syringes (Drug Reconstitution Delivery Systems)
9.2.3.3. Auto-Injector Platform
9.2.3.4. Wearable Injector Platform
9.2.3.5. Ocular Delivery Systems
9.2.3.6. Novel Delivery Systems
9.2.4. Recent Developments
9.2.4.1. Partnership with Novartis
9.2.4.2. Partnership with A Global Pharmaceutical Company (undisclosed)
9.2.4.3. Partnership with Medimmune
9.2.4.4. Partnership with Hikma
9.2.4.5. Partnership with Sanofi
9.2.4.6. Partnership with Biodel
9.2.5. Future Outlook
 
9.3. West Pharmaceuticals
9.3.1. Overview and Background
9.3.2. Financial Performance
9.3.3. Product Portfolio
9.3.3.1. Marketed Products
9.3.3.2. Pipeline Products
9.3.4. Recent Developments
9.3.4.1. Advancing The Growth Of CZ Syringes
9.3.4.2. Looking to Grow in Pharmerging Markets (Brazil, China, India)
9.3.4.3. Agreement with Janssen Biotech
9.3.5. Future Outlook
 
9.4. BD Medical, A Segment Of Becton, Dickinson and Company
9.4.1. Overview and Background
9.4.2. Financial Performance
9.4.3. Product Portfolio
9.4.4. Recent Developments
9.4.4.1. Agreement with Biodel
9.4.4.2. Collaboration with World Health Organization (WHO)
9.4.4.3. Launch of BD Sterifill Advance
9.4.4.4. Entering the Generic Business
9.4.4.5. Acquisition of Cato Software Solutions
9.4.4.6. Acquisition of Safety Syringes
9.4.5. Future Outlook
 
9.5. Smiths Medical
9.5.1. Overview and Background
9.5.2. Financial Performance
9.5.3. Product Portfolio
9.5.4. Recent Developments
9.5.5. Future Outlook
 
9.6. Catalent
9.6.1. Financial Performance
9.6.2. Product Portfolio
9.6.3. Recent Developments
9.6.4. Future Outlook
 
9.7. Terumo Medical Corporation
9.7.1. Financial Performance
9.7.2. Product Portfolio
9.7.3. Recent Developments
9.7.3.1. Agreement with CareFusion
9.7.3.2. Growing Focus on Safety Devices
9.7.3.3. Launch of SurGuard3
9.7.4. Future Outlook
 
9.8. Covidien
9.8.1. Financial Performance
9.8.2. Product Portfolio
9.8.3. Future Outlook
 
10. REGIONAL/OTHER NEEDLE BASED SAFETY DEVICES MANUFACTURERS
10.1. Chapter Overview
10.2. Regional Safety Injection Device Manufacturers: Comparative Landscape
10.3. Revolutions Medical Corporation
10.4. Beipu
10.5. Formosa Medical Devices
10.6. UNIQSAFE Biomeditech Company
10.7. Taisei Kako
 
11. SWOT ANALYSIS
11.1. Chapter Overview
11.2. Strengths
11.3. Weaknesses
11.4. Opportunities
11.5. Threats
 
12. INTERVIEW TRANSCRIPTS
 
13. CONCLUSION
13.1. Transition From Conventional Devices To Safety Injection Devices
13.2. Technological Advancements Have Ensured That These Devices Continue to Gain Traction From Healthcare Practitioners And Patients Alike
13.3. A Multi-Billion Dollar Rapidly Growing Market
13.4. Concluding Remarks
 
14. APPENDIX 1: TABULATED DATA
 
15. APPENDIX 2: LIST OF COMPANIES

List of Figures

Figure 3.1  Occurrence of Needlestick Injuries
Figure 4.1  Safety Injection Devices: Distribution by Type
Figure 4.2  Safety Injection Devices: Distribution by Companies
Figure 4.3  Safety Injection Devices: Leading Companies
Figure 5.1  Types of Safety Syringes
Figure 5.2  Safety Syringes: Distribution by Type
Figure 5.3  Safety Syringes: Distribution by Mode of Activation
Figure 5.4  Safety Syringes: Analysis by Price
Figure 5.5  Safety Syringes: Product Competitiveness Analysis
Figure 5.6  Safety Syringes: Product Profiling Framework
Figure 6.1 Safety Needles: Distribution by Mode of Activation
Figure 6.2  Safety Needles: Analysis by Price
Figure 6.3  Safety Needles: Product Profiling Framework
Figure 8.1  Overall Safety Syringes Market, Short-Mid Term (2014 - 2019): Base Scenario (Billion Units)
Figure 8.2  Overall Safety Syringes Market, Long Term (2019 - 2024): Base Scenario (Billion Units)
Figure 8.3  Overall Safety Syringes Market, Short-Mid Term (2014 - 2019): Base Scenario (USD Billion)
Figure 8.4  Overall Safety Syringes Market, Long Term (2019 - 2024): Base Scenario (USD Billion)
Figure 8.5  Number of Retractable Safety Syringes, Short-Mid Term (2014 - 2019): Base Scenario (Billion Units)
Figure 8.6  Number of Retractable Safety Syringes, Long Term (2019 - 2024): Base Scenario (Billion Units)
Figure 8.7  Retractable Syringes, 2014-2024: Distribution by Price Tiers
Figure 8.8  Retractable Safety Syringe Market, Short-Mid Term (2014 - 2019): Base Scenario (USD Billion)
Figure 8.9  Retractable Safety Syringe Market, Long Term (2019 - 2024): Base Scenario (USD Billion)
Figure 8.10  Number of Non-Retractable Safety Syringes, Short-Mid Term (2014 - 2019): Base Scenario (Billion Units)
Figure 8.11  Number of Non-Retractable Safety Syringes, Long Term (2019 - 2024): Base Scenario (Billion Units)
Figure 8.12  Non-retractable Syringes, 2014-2024: Distribution by Price Tiers
Figure 8.13  Non-Retractable Safety Syringe Market, Short-Mid Term (2014 - 2019): Base Scenario (USD Billion)
Figure 8.14 Non-Retractable Safety Syringe Market, Long Term (2019 -2024): Base Scenario (USD Billion)
Figure 9.1  Revenues, Unilife Corporation, FY 2011 - FY 2013 (USD ‘000)
Figure 9.2  West Pharmaceutical Services: Revenues, 2009-2013 (USD Million)
Figure 9.3  West Pharmaceutical Services: Revenues by Business Segments, 2011-2013 (USD Million)
Figure 9.4  Becton Dickinson: Revenues, 2009-2013 (USD Million)
Figure 9.5  Becton Dickinson: Revenues by Business Divisions, 2013 (USD Billion, %)
Figure 9.6  BD Medical: Revenues by Business Divisions, 2013 (USD Billion, %)
Figure 9.7  Smiths Group: Revenues, 2009-2013 (GBP Million)
Figure 9.8  Smiths Group: Revenues by Business Divisions, FY 2013 (GBP Million)
Figure 9.9  Smiths Medical: Revenues by Business Segments, FY 2012 - FY 2013 (GBP Million)
Figure 9.10  Catalent: Revenues, 2009-2013 (USD Million)
Figure 9.11  Catalent: Revenues by Business Segments, FY 2013 (USD Million)
Figure 9.12 Terumo Corporation: Revenues, FY09-FY 13 (JPY Billion)
Figure 9.13  Terumo Corporation: Revenues by Business Segments, FY 2013 (JPY Billion)
Figure 9.14  Covidien: Revenues, 2009-2013 (USD Million)
Figure 9.15  Covidien: Revenues by Business Segments, 2012-2013 (USD Million)
Figure 9.16  Covidien Medical Supplies: Revenues by Product Segments, 2013 (USD Million)
Figure 13.1  Safety Syringes Market (USD Billion): Comparative Scenarios, 2014, 2019 and 2024

List of Tables

Table 3.1  Blood-borne Infections: Frequency of Occurrence
Table 3.2 Needle Safety: State Legislations
Table 4.1  List of Safety Injection Devices
Table 4.2  Cost Comparison: Safety Syringe and Conventional Syringe
Table 4.3  List of Safety Blood Collection / Infusion Sets
Table 4.4 Auto-injector/Pen-injector Systems Approved in 2013-2014
Table 4.5 Auto-injector/Pen-injector Systems (Using Prefilled Syringes) Available in the Market
Table 4.6  List of Blunt Fill Needles
Table 4.7  List of Needleless Injection Systems
Table 5.1  List of Retractable Safety Syringes
Table 5.2  Non Retractable Syringes: Disadvantages
Table 5.3  List of Non-Retractable Safety Syringes
Table 5.4  Safety Syringes: Purchase Price
Table 5.5  VanishPoint Syringe: Needle Size Description
Table 5.6 MySafety Syringe: Needle Size Description
Table 5.7  MySafety Syringe: Approval History
Table 5.8  Difference between SafePro Series and SafePro Plus Series
Table 5.9  SafePro Plus Safety Syringe: Needle Size Description
Table 5.10  UNIQSAFE Safety Syringe: Needle Size Description
Table 5.11  BD Safety-Lok Syringe: Needle Size Description
Table 6.1  List of Active Safety Needles
Table 6.2  List of Passive Safety Needles
Table 6.3  Safety Needles: Purchase Price
Table 6.4  K-Pack Surshield: Key Specifications
Table 6.5  Difference betweenSurGuard3 and SurGuard2 Safety Needle
Table 6.6  SurGuard3 Safety Needle: Needle Size Description
Table 6.7  BD SafetyGlide Shielding Hypodermic Needle: Key Specifications
Table 6.8  BD SafetyGlide Hypodermic Shielding Needle: Needle Size Description
Table 7.1  List of Marketed Drugs in/with Safety Devices
Table 7.2  Safety Injection Devices: Deals and Partnerships
Table 8.1  Retractable Syringes: Price Points
Table 8.2  Non-retractable Syringes: Price Points
Table 9.1  Becton Dickinson: List of Safety Injection Devices
Table 9.2  Terumo: Financial Targets of Mid-term Plan
Table 10.1  Regional Safety Injection Device Manufacturers: Comparison of Product Portfolio
Table 11.1  SWOT Analysis
Table 11.2  Recall of Autoinjectors
Table 11.3 Prefilled Syringe Recalls, 2003-2014
Table 13.1   Safety Syringes: Analysis by Volume
Table 14.1  Safety Injection Devices: Distribution by Type
Table 14.2  Safety Injection Devices: Distribution by Companies
Table 14.3  Safety Injection Devices: Leading Companies
Table 14.4  Safety Syringes: Distribution by Type
Table 14.5  Safety Syringes: Distribution by Mode of Activation
Table 14.6  Safety Needles: Distribution by Mode of Activation
Table 14.7  Overall Safety Syringes Market, Short-Mid Term (2014 – 2019): Base Scenario (Billion Units)
Table 14.8  Overall Safety Syringes Market, Long Term (2019 – 2024): Base Scenario (Billion Units)
Table 14.9  Overall Safety Syringes Market, Short-Mid Term (2014 – 2019): Conservative Scenario (Billion Units)
Table 14.10  Overall Safety Syringes Market, Long Term (2019 – 2024): Conservative Scenario (Billion Units)
Table 14.11  Overall Safety Syringes Market, Short-Mid Term (2014 – 2019): Optimistic Scenario (Billion Units)
Table 14.12  Overall Safety Syringes Market, Long Term (2019 – 2024): Optimistic Scenario (Billion Units)
Table 14.13  Overall Safety Syringes Market, Short-Mid Term (2014 – 2019): Base Scenario (USD Billion)
Table 14.14  Overall Safety Syringes Market, Long Term (2019 – 2024): Base Scenario (USD Billion)
Table 14.15  Overall Safety Syringes Market, Short-Mid Term (2014 – 2019): Conservative Scenario (USD Billion)
Table 14.16  Overall Safety Syringes Market, Long Term (2019 – 2024): Conservative Scenario (USD Billion)
Table 14.17  Overall Safety Syringes Market, Short-Mid Term (2014 – 2019): Optimistic Scenario (USD Billion)
Table 14.18  Overall Safety Syringes Market, Long Term (2019 – 2024): Optimistic Scenario (USD Billion)
Table 14.19  Number of Retractable Safety Syringes, Short-Mid Term (2014 – 2019): Base Scenario (Billion Units)
Table 14.20  Number of Retractable Safety Syringes, Long Term (2019 – 2024): Base Scenario (Billion Units)
Table 14.21  Number of Retractable Safety Syringes, Short-Mid Term (2014 – 2019): Conservative Scenario (Billion Units)
Table 14.22  Number of Retractable Safety Syringes, Long Term (2019 – 2024): Conservative Scenario (Billion Units)
Table 14.23  Number of Retractable Safety Syringes, Short-Mid Term (2014 – 2019): Optimistic Scenario (Billion Units)
Table 14.24  Number of Retractable Safety Syringes, Long Term (2019 – 2024): Optimistic Scenario (Billion Units)
Table 14.25  Retractable Safety Syringe Market, Short-Mid Term (2014 – 2019): Base Scenario (USD Billion)
Table 14.26  Retractable Safety Syringe Market, Long Term (2019 – 2024): Base Scenario (USD Billion)
Table 14.27  Retractable Safety Syringe Market, Short-Mid Term (2014 – 2019): Conservative Scenario (USD Billion)
Table 14.28  Retractable Safety Syringe Market, Long Term (2019 – 2024): Conservative Scenario (USD Billion)
Table 14.29  Retractable Safety Syringe Market, Short-Mid Term (2014 – 2019): Optimistic Scenario (USD Billion)
Table 14.30  Retractable Safety Syringe Market, Long Term (2019 – 2024): Optimistic Scenario (USD Billion)
Table 14.31  Number of Non-Retractable Safety Syringes, Short-Mid Term (2014 – 2019): Base Scenario (Billion Units)
Table 14.32  Number of Non-Retractable Safety Syringes, Long Term (2019 – 2024): Base Scenario (Billion Units)
Table 14.33  Number of Non-Retractable Safety Syringes, Short-Mid Term (2014 – 2019): Conservative Scenario (Billion Units)
Table 14.34  Number of Non-Retractable Safety Syringes, Long Term (2019 – 2024): Conservative Scenario (Billion Units)
Table 14.35  Number of Non-Retractable Safety Syringes, Short-Mid Term (2014 – 2019): Optimistic Scenario (Billion Units)
Table 14.36  Number of Non-Retractable Safety Syringes, Long Term (2019 – 2024): Optimistic Scenario (Billion Units)
Table 14.37  Non-Retractable Safety Syringe Market, Short-Mid Term (2014 – 2019): Base Scenario (USD Billion)
Table 14.38  Non-Retractable Safety Syringe Market, Long Term (2019 – 2024): Base Scenario (USD Billion)
Table 14.39  Non-Retractable Safety Syringe Market, Short-Mid Term (2014 – 2019): Conservative Scenario (USD Billion)
Table 14.40  Non-Retractable Safety Syringe Market, Long Term (2019 – 2024): Conservative Scenario (USD Billion)
Table 14.41  Non-Retractable Safety Syringe Market, Short-Mid Term (2014 – 2019): Optimistic Scenario (USD Billion)
Table 14.42  Non-Retractable Safety Syringe Market, Long Term (2019 – 2024): Optimistic Scenario (USD Billion)
Table 14.43  Revenues, Unilife Corporation, FY 2011 - FY 2013 (USD ‘000)
Table 14.44  West Pharmaceutical Services: Revenues, 2009-2013 (USD Million)
Table 14.45  West Pharmaceutical Services: Revenues by Business Segments, 2011-2013 (USD Million)
Table 14.46  Becton Dickinson: Revenues, 2009-2013 (USD Million)
Table 14.47  Becton Dickinson: Revenues by Business Divisions, 2013 (USD Billion, %)
Table 14.48  BD Medical: Revenues by Business Segments, 2013 (USD Billion, %)
Table 14.49  Smiths Group: Revenues, 2009-2013 (GBP Million)
Table 14.50  Smiths Group: Revenues by Business Divisions, FY 2013 (GBP Million)
Table 14.51  Smiths Medical: Revenues by Business Segments, FY 2012 - FY 2013 (GBP Million)
Table 14.52  Catalent: Revenues, 2009-2013 (USD Million)
Table 14.53  Catalent: Revenues by Business Divisions, FY 2013 (USD Million)
Table 14.54  Terumo Corporation: Revenues, FY09-FY 13 (JPY Billion)
Table 14.55  Terumo Corporation: Revenues by Business Segments, FY 2013 (JPY Billion)
Table 14.56  Covidien: Revenues, 2009-2013 (USD Million)
Table 14.57  Covidien: Revenues by Business Segments, 2012-2013 (USD Million)
Table 14.58  Covidien Medical Supplies: Revenues by Product Segments, 2013 (USD Million)
Table 14.59  Safety Syringes Market (USD Billion) Forecast: 2014, 2019 and 2024

Listed Companies

The following companies have been mentioned in this report.

  1. Activa
  2. AGN Tech
  3. AMB
  4. Antares Pharma
  5. Applied Medical Technology
  6. Aptar Pharma
  7. Aradigm Corporation
  8. AstraZeneca
  9. Autosafe-Reflex
  10. AxelBioCorp
  11. B. Braun Medical Inc.
  12. Bang and Olufsen
  13. Bard Access Systems
  14. Becton Dickinson
  15. Beipu
  16. Bespak
  17. Biodel
  18. Bioject Medical Technologies, Inc.
  19. Cardinal Health Nuclear Pharmaceutical Services
  20. CareFusion
  21. Catalent 
  22. Cato Software Solutions
  23. CeifiT
  24. Churchill Medical Systems
  25. Covidien (Kendall Healthcare)
  26. DMC Medical
  27. DuoProSS Meditech Corp
  28. Elcam Medical
  29. EMD Serono/Pfizer
  30. Eternity Healthcare
  31. Ethicon, Inc.
  32. Evans Enterprise
  33. Formosa Medical Devices
  34. Globe Medical Tech, Inc.
  35. Greiner bio-one
  36. Haselmeier
  37. Health for personal Care
  38. Hectare Systems
  39. Hikma Pharmaceuticals
  40. Hospira
  41. ICU Medical
  42. Injex - Equidyne Systems
  43. Innovate UK
  44. Inviro Medical
  45. ITL (Innovating Technologies for Life) North America
  46. Janssen Biotech
  47. Kaleo Inc.
  48. Kawasumi Laboratories
  49. Med-Design Corporation
  50. Medex
  51. Medical Device Manufacturer (Thailand) Ltd
  52. MedicalChain International Corporation (MCI) 
  53. Medicina
  54. Medigard
  55. Mediject
  56. MEDIpoint Inc.
  57. Medisytems, a NxStage Company
  58. Medpro Safety Products
  59. Meridian
  60. Microsharp Needles Pvt. Limited
  61. National Medical Products, Inc.
  62. New Wave Surgical Corp
  63. Nexus Medical
  64. Nipro
  65. Novo Nordisk A/S
  66. Owen Mumford
  67. PA Consulting
  68. Penjet corporation
  69. PlastefInvestissements SA
  70. Polymed Medical Devices
  71. Protectus Medical Devices, Inc.
  72. Q Stat  
  73. Raumedic
  74. Retractable Technologies, Inc. 
  75. Revolutions Medical Corporation Inc.
  76. Rexam Pharma
  77. SafeShot Technologies
  78. Safety Medical Products Limited
  79. Safety Medical Supply Intl. 
  80. Safety Syringes, Inc
  81. Sanofi
  82. Santa Monica
  83. Sarstedt, Inc.
  84. Scandinavian Health Limited (SHL Medical)
  85. Schreiner MediPharm
  86. Scivanta Medical Corporation
  87. Septodont, Inc.
  88. SHL Medical
  89. SHPI
  90. Smiths Medical
  91. Sol-Millennium
  92. STA.MED
  93. Star Syringe Ltd
  94. Suzuken Co., Ltd.
  95. Synthecon
  96. Syringex Medical
  97. Taisei Kako
  98. Terumo Medical Corp.
  99. The Medical House
  100. U.S. Medical Instruments
  101. Unilife Corporation
  102. UNIQSAFE Biomeditech Company
  103. Valeritas
  104. Vätterledens Invest
  105. Vigmed
  106. Vital Signs
  107. Weimer Pharma 
  108. West Pharmaceutical Services
  109. Westmed, Inc.
  110. Ypsomed
  111. ZEON
  112. Zhejiang Zheda Medical Instrument Co. Ltd.

Request Customization

Please select a suitable option for customization in the report

PRICING DETAILS

USD 1,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site / office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm / enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com